Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Healthcare Psychedelics
Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp > will again be an exciting week for Champignon brands
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by cautiousguyon Dec 14, 2020 11:23am
246 Views
Post# 32099665

RE:will again be an exciting week for Champignon brands

RE:will again be an exciting week for Champignon brands
disosa wrote: one of the coming weeks  hopefully the halt will be lifted and we we get a lot of new PR (as the company told us) to tell what they have been doing last 6 months.
if you look how hot the sector is,SHRM(SHRMF) has still a lot of potential ans is undervalued now.

SHRM(F) could be the stock of 2021.
when people like cautionguy sell when the halt is lifted,that  will be a great buying opportunity for others.

now ,we need some new fuel(PR) and resume trading SHRM.




Yeah you keep telling yourself.  Nothing like "need[ing]  some new fuel (PR)" to lift a halt and resume trading.  Don't need a revamped board, a criminal investigation, a new CEO, or CFO, or a new long range plan.   Just need some "new fuel (PR)".  Very deserving of three thumbs up. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities